Literature DB >> 17027924

Fucoidan prevents C epsilon germline transcription and NFkappaB p52 translocation for IgE production in B cells.

Souichi Oomizu1, Yuhki Yanase, Hidenori Suzuki, Yoshikazu Kameyoshi, Michihiro Hide.   

Abstract

Fucoidan, a dietary fiber contained in seaweed, reduces the increase of antigen-specific IgE in mice exposed to ovalbumin. In this study, we investigated the effect of fucoidan on IgE production and intracellular events in B cells in vitro. Fucoidan inhibited the production of IgE and C epsilon germline transcription in murine B cells induced by IL-4 (100 ng/ml) and anti-CD40 antibodies (10 microg/ml), whereas it stimulated cell proliferation. A significant effect of fucoidan on IgE production was observed when B cells were stimulated with a higher dose (5 microg/ml) of anti-CD40 antibodies, but not when stimulated with lower doses (1.25, 2.5 microg/ml), regardless of the IL-4 concentrations. Moreover, nuclear translocation of NFkappaB p52, but neither that of NFkappaB p65, nor the phosphorylation of JAK1 and STAT6 was reduced by fucoidan. These results suggest that fucoidan inhibited IgE production by preventing the NFkappaB p52-mediated pathways activated by CD40.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027924     DOI: 10.1016/j.bbrc.2006.08.009

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Fucoidan enhances the survival and sustains the number of splenic dendritic cells in mouse endotoxemia.

Authors:  Eun-Ju Ko; Hong-Gu Joo
Journal:  Korean J Physiol Pharmacol       Date:  2011-04-30       Impact factor: 2.016

2.  Fucoidan increases TNF-alpha-induced MMP-9 secretion in monocytic cell line U937.

Authors:  Jintang Sun; Alei Feng; Yun Zhang; Shanzhen Sun; Weixu Hu; Meixiang Yang; Fengcai Wei; Xun Qu
Journal:  Inflamm Res       Date:  2009-09-23       Impact factor: 4.575

3.  Evaluation of adjuvant effects of fucoidan for improving vaccine efficacy.

Authors:  Su-Yeon Kim; Hong-Gu Joo
Journal:  J Vet Sci       Date:  2014-12-24       Impact factor: 1.672

4.  F-fucoidan from Saccharina japonica is a novel inducer of galectin-9 and exhibits anti-allergic activity.

Authors:  Yuka Tanino; Takashi Hashimoto; Takao Ojima; Masashi Mizuno
Journal:  J Clin Biochem Nutr       Date:  2016-05-21       Impact factor: 3.114

5.  The Role of Fucoidans Isolated from the Sporophylls of Undaria pinnatifida against Particulate-Matter-Induced Allergic Airway Inflammation: Evidence of the Attenuation of Oxidative Stress and Inflammatory Responses.

Authors:  Kalahe Hewage Iresha Nadeeka Madushani Herath; Hyo Jin Kim; Areum Kim; Chung Eui Sook; Boo-Yong Lee; Youngheun Jee
Journal:  Molecules       Date:  2020-06-22       Impact factor: 4.411

6.  Marine Ingredients for Sensitive Skin: Market Overview.

Authors:  Marta Salvador Ferreira; Diana I S P Resende; José M Sousa Lobo; Emília Sousa; Isabel F Almeida
Journal:  Mar Drugs       Date:  2021-08-17       Impact factor: 5.118

Review 7.  Fucoidans and Bowel Health.

Authors:  Jin-Young Yang; Sun Young Lim
Journal:  Mar Drugs       Date:  2021-07-30       Impact factor: 5.118

8.  Sulfated Fucogalactan From Laminaria Japonica Ameliorates β-Cell Failure by Attenuating Mitochondrial Dysfunction via SIRT1-PGC1-α Signaling Pathway Activation.

Authors:  Nan Wu; Weihua Jin; Yuchen Zhao; Hong Wang; Sunyue He; Wenjing Zhang; Jiaqiang Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-13       Impact factor: 6.055

Review 9.  Looking Beyond the Terrestrial: The Potential of Seaweed Derived Bioactives to Treat Non-Communicable Diseases.

Authors:  Kenneth G Collins; Gerald F Fitzgerald; Catherine Stanton; R Paul Ross
Journal:  Mar Drugs       Date:  2016-03-18       Impact factor: 5.118

Review 10.  Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.

Authors:  Michael R Edwards; Nathan W Bartlett; Deborah Clarke; Mark Birrell; Maria Belvisi; Sebastian L Johnston
Journal:  Pharmacol Ther       Date:  2008-10-06       Impact factor: 12.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.